Curt Balch

3.0k total citations · 1 hit paper
44 papers, 2.4k citations indexed

About

Curt Balch is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Curt Balch has authored 44 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 12 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Curt Balch's work include Epigenetics and DNA Methylation (21 papers), Histone Deacetylase Inhibitors Research (8 papers) and Cancer-related gene regulation (7 papers). Curt Balch is often cited by papers focused on Epigenetics and DNA Methylation (21 papers), Histone Deacetylase Inhibitors Research (8 papers) and Cancer-related gene regulation (7 papers). Curt Balch collaborates with scholars based in United States, South Korea and China. Curt Balch's co-authors include Kenneth P. Nephew, Daniela Matei, Pearlly S. Yan, Jeanne M. Schilder, Michael W.Y. Chan, Hung‐Cheng Lai, Shu Zhang, Tim H-M. Huang, Fang Fang and Amit K. Tiwari and has published in prestigious journals such as Bioinformatics, PLoS ONE and Endocrine Reviews.

In The Last Decade

Curt Balch

41 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors

2008 1.1k citations Shu Zhang, Curt Balch et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Curt Balch United States	19	1.7k	971	759	202	175	44	2.4k
Radosław Januchowski Poland	24	1.1k 0.6×	736 0.8×	476 0.6×	201 1.0×	224 1.3×	53	1.8k
Sara Ricardo Portugal	22	879 0.5×	874 0.9×	487 0.6×	80 0.4×	219 1.3×	54	1.7k
Danhui Weng China	22	926 0.6×	492 0.5×	471 0.6×	227 1.1×	160 0.9×	41	1.5k
Susan Mason United Kingdom	17	1.4k 0.8×	648 0.7×	673 0.9×	64 0.3×	356 2.0×	33	2.1k
Douglas R. Hurst United States	25	1.8k 1.1×	819 0.8×	1.0k 1.4×	66 0.3×	187 1.1×	63	2.7k
Bhuvanesh Dave United States	24	1.3k 0.8×	1.3k 1.3×	442 0.6×	59 0.3×	198 1.1×	39	2.6k
Simona Mozzetti Italy	23	1.4k 0.8×	798 0.8×	403 0.5×	151 0.7×	150 0.9×	35	2.3k
Gregory J. Riggins United States	21	1.0k 0.6×	432 0.4×	326 0.4×	136 0.7×	116 0.7×	35	1.9k
Silvia Di Agostino Italy	35	2.5k 1.5×	1.4k 1.4×	1.0k 1.3×	187 0.9×	164 0.9×	66	3.6k
Imayavaramban Lakshmanan United States	27	1.5k 0.9×	961 1.0×	407 0.5×	70 0.3×	504 2.9×	43	2.2k

Countries citing papers authored by Curt Balch

Since Specialization

Citations

This map shows the geographic impact of Curt Balch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Curt Balch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Curt Balch more than expected).

Fields of papers citing papers by Curt Balch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Curt Balch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Curt Balch. The network helps show where Curt Balch may publish in the future.

Co-authorship network of co-authors of Curt Balch

This figure shows the co-authorship network connecting the top 25 collaborators of Curt Balch. A scholar is included among the top collaborators of Curt Balch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Curt Balch. Curt Balch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kropf, Patricia, Woonbok Chung, Lianchun Xiao, et al.. (2025). A phase 2 study of decitabine with or without carboplatin and arsenic trioxide in patients with MDS and AML. PubMed. 2(2). 100071–100071.

Athavale, Dipti, Curt Balch, Yanting Zhang, Xiaodan Yao, & Shumei Song. (2024). The role of Hippo/YAP1 in cancer-associated fibroblasts: Literature review and future perspectives. Cancer Letters. 604. 217244–217244. 8 indexed citations

Chang, Jane, Curt Balch, & Hyung Suk Oh. (2024). Toward the Eradication of Herpes Simplex Virus: Vaccination and Beyond. Viruses. 16(9). 1476–1476. 8 indexed citations

Ghebremedhin, Anghesom, Dipti Athavale, Yanting Zhang, et al.. (2024). Tumor-Associated Macrophages as Major Immunosuppressive Cells in the Tumor Microenvironment. Cancers. 16(19). 3410–3410. 17 indexed citations

Chang, Jane, et al.. (2023). A Narrative Review of Alternative Symptomatic Treatments for Herpes Simplex Virus. Viruses. 15(6). 1314–1314. 13 indexed citations

Balch, Curt, et al.. (2017). The Epigenomics of Embryonic Pathway Signaling in Colorectal Cancer. Frontiers in Pharmacology. 8. 267–267. 24 indexed citations

Karthikeyan, Chandrabose, Charles R. Ashby, Haneen Amawi, et al.. (2016). Pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinolines: Novel compounds that reverse ABCG2-mediated resistance in cancer cells. Cancer Letters. 376(1). 118–126. 28 indexed citations

Hussain, Saad Abdulrahman, et al.. (2016). Natural Polyphenols in Cancer Chemoresistance. Nutrition and Cancer. 68(6). 879–891. 51 indexed citations

Zhou, Ao, Meng Li, Bo He, et al.. (2016). Lipopolysaccharide treatment induces genome-wide pre-mRNA splicing pattern changes in mouse bone marrow stromal stem cells. BMC Genomics. 17(S7). 509–509. 6 indexed citations

10.

Nam, Seungyoon, Hae Ryung Chang, Hae Rim Jung, et al.. (2014). A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancer. Cancer Letters. 356(2). 880–890. 29 indexed citations

11.

Kwon, Chang-Hyuk, Hyosun Tak, Mina Rho, et al.. (2014). Detection of PIWI and piRNAs in the mitochondria of mammalian cancer cells. Biochemical and Biophysical Research Communications. 446(1). 218–223. 61 indexed citations

12.

Yo, Yi-Te, Yu-Chi Wang, Curt Balch, et al.. (2012). Growth Inhibition of Ovarian Tumor–Initiating Cells by Niclosamide. Molecular Cancer Therapeutics. 11(8). 1703–1712. 105 indexed citations

13.

Balch, Curt, et al.. (2012). A unique histone deacetylase inhibitor alters microRNA expression and signal transduction in chemoresistant ovarian cancer cells. Cancer Biology & Therapy. 13(8). 681–693. 19 indexed citations

14.

Balch, Curt & Kenneth P. Nephew. (2012). Epigenetic Targeting Therapies to Overcome Chemotherapy Resistance. Advances in experimental medicine and biology. 754. 285–311. 21 indexed citations

15.

Fang, Fang, Curt Balch, Jeanne M. Schilder, et al.. (2010). A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum‐resistant, epithelial ovarian cancer. Cancer. 116(17). 4043–4053. 139 indexed citations

16.

Bapat, Sharmila A., Victor X. Jin, Curt Balch, et al.. (2010). Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells. Epigenetics. 5(8). 716–729. 42 indexed citations

17.

Yang, Yating, et al.. (2009). A Rationally Designed Histone Deacetylase Inhibitor with Distinct Antitumor Activity against Ovarian Cancer. IUScholarWorks (Indiana University). 1 indexed citations

18.

Li, Meng, Curt Balch, Jae Hoon Chung, et al.. (2009). Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer. BMC Medical Genomics. 2(1). 34–34. 189 indexed citations

19.

Zhang, Shu, Curt Balch, Michael W.Y. Chan, et al.. (2008). Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors. Cancer Research. 68(11). 4311–4320. 1055 indexed citations breakdown →

20.

Nephew, Kenneth P., Curt Balch, & David G. Skalnik. (2008). Methyl Group Acceptance Assay for the Determination of Global DNA Methylation Levels. Methods in molecular biology. 507. 35–41. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact